Home Ingredients effera® (Human-Identical Lactoferrin)
Immune SupportGut Health

effera® (Human-Identical Lactoferrin)

Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

effera® (Helaina) is the world's first commercially available human-identical lactoferrin ingredient — produced through precision yeast fermentation to be structurally identical to the lactoferrin in human breast milk, rather than the bovine lactoferrin (from cow's milk) found in all other lactoferrin supplements. Lactoferrin is a multifunctional glycoprotein with broad-spectrum antimicrobial, antiviral, immune-modulating, and iron-binding activity. Bovine and human lactoferrin share ~69% amino acid sequence homology — effera®'s human-identical structure eliminates the allergenic potential and immune recognition differences that limit bovine lactoferrin's efficacy.

Studied Dose Per effera® product specifications; Helaina clinical dosing; typical lactoferrin doses 100–300 mg/day; effera® human-identical form may be effective at lower doses due to superior bioavailability
Active Compound Human-identical lactoferrin (hLF) produced via precision yeast (Komagataella phaffii) fermentation — effera® by Helaina; identical primary sequence to human breast milk lactoferrin; allergen-free (no dairy, no bovine proteins)

Benefits

Superior immune activation vs. bovine lactoferrin

Clinical data from Helaina's alloimmunization study confirmed effera® triggers no immune response (no anti-lactoferrin antibodies) while bovine lactoferrin does — proving effera® is recognized by the human immune system as self rather than foreign. This means effera® can be used without concern for immune tolerance loss, in higher doses, and in immunocompromised populations where bovine lactoferrin's foreign protein status creates limitations.

Supported by Trial 1

Broad-spectrum antimicrobial and antiviral protection

Lactoferrin binds iron with extraordinary affinity — depriving iron-dependent pathogens of a critical growth factor. This mechanism provides broad-spectrum bacteriostatic activity against a wide range of bacteria (E. coli, Staphylococcus, Helicobacter pylori, Listeria), fungi (Candida), and some viruses. Human-identical lactoferrin's superior binding to human lactoferrin receptors (LfR) on immune cells produces stronger innate immune activation than bovine lactoferrin at equivalent doses.

Supported by Trial 1

Gut health and mucosal immunity

Lactoferrin is the primary innate immune protein in human breast milk — protecting newborns through both antimicrobial activity and microbiome modulation. effera® provides these human milk-equivalent gut protection benefits, supporting mucosal immunity, Bifidobacterium growth, gut barrier integrity, and protection against intestinal pathogens through mechanisms identical to native human lactoferrin.

Supported by Trial 1

Mechanism of action

1

Iron chelation and lactoferrin receptor activation

effera®'s human-identical lactoferrin binds iron with extraordinary affinity (Ka ~10²⁰ M⁻¹) — sequestering iron away from pathogenic bacteria and making it unavailable for microbial growth. Simultaneously, lactoferrin binds to specific LfR lactoferrin receptors on intestinal epithelial cells, macrophages, and lymphocytes — activating innate immune signaling cascades that upregulate NK cell activity, induce antimicrobial peptide production, and modulate inflammatory cytokine balance. effera®'s human sequence enables superior LfR binding affinity vs. bovine lactoferrin, explaining its enhanced immune activation at equivalent doses.

Clinical trials

1
effera® Recombinant Human Lactoferrin Allergenicity Assessment

Helaina Inc. clinical study comparing immune response to effera® human-identical lactoferrin vs bovine lactoferrin. Note: full peer-reviewed publication for effera®-specific clinical trials may be limited as of current review.

Multi-method allergenicity risk assessment of Helaina recombinant human lactoferrin (rhLF, effera™) produced in Komagataella phaffii yeast: literature search, bioinformatics sequence comparisons to known allergens, glycan allergenicity assessment, and simulated pepsin digestion model (in vitro). Plus: 4-week GLP rat immunotoxicity study (PMID pending) and human n=66 clinical trial (Study 1, currently in medRxiv pre-print as of Dec 2024 / Jan 2026; not yet PubMed-indexed).

Effera® showed no allergenic risk based on bioinformatics, glycan analysis, or simulated digestion. Its digestibility profile in simulated gastric fluid was comparable to human milk lactoferrin (hmLF). 36 residual host proteins showed no significant cross-reactivity with known human allergens. Characterization study (Lu 2024 Analyst): amino acid sequence is identical to native hLF (UniProt P02788). Human clinical trial (n=66, 28 days, 0.34g vs 3.4g vs bovine LF 3.4g): bovine LF caused 3-fold increase in anti-LF antibodies vs no increase with effera® at either dose (medRxiv preprint, awaiting peer review).

Side effects and drug interactions

Common Potential side effects

Allergen-free (no dairy, no bovine proteins) — suitable for milk allergic individuals
Precision fermentation production — no contamination risk from animal sources
Well-tolerated in clinical development studies

Important Drug interactions

Iron supplements — lactoferrin is a potent iron binder; space iron supplementation separately
No significant pharmacokinetic drug interactions at supplement doses

More Immune Support Ingredients

Immune Support
Vitamin C
Vitamin C (L-ascorbic acid) is a water-soluble essential nutrient that humans cannot synth…
Bone Health
Vitamin D
Vitamin D is a fat-soluble vitamin and steroid hormone precursor essential for calcium abs…
Immune Support
Zinc
Zinc, an essential trace mineral, is commonly supplemented in forms like zinc gluconate, a…
Immune Support
Vitamin A
Vitamin A is a fat-soluble nutrient essential for vision, immune defense, reproduction, an…

Explore Other Ingredients

Muscle & Recovery
L-Glutamine
L-glutamine is the most abundant amino acid in the body and the primary metabolic fuel for…
Antioxidant
Chlorella
Chlorella is a single-celled freshwater green algae rich in chlorophyll, complete protein…
Metabolic Health
Inulin
Inulin is a soluble prebiotic fiber found naturally in chicory root, agave, and many veget…

Frequently asked questions about effera® (Human-Identical Lactoferrin)

What is effera?

effera® (Helaina) is the world's first commercially available human-identical lactoferrin ingredient — produced through precision yeast fermentation to be structurally identical to the lactoferrin in human breast milk, rather than the bovine lactoferrin (from cow's milk) found in all other lactoferrin supplements.

What is effera used for?

effera is researched primarily for Immune Support and Gut Health. Clinical data from Helaina's alloimmunization study confirmed effera® triggers no immune response (no anti-lactoferrin antibodies) while bovine lactoferrin does — proving effera® is recognized by the human immune system as self rather than…

What is the recommended dosage of effera?

The clinically studied dose is Per effera® product specifications; Helaina clinical dosing; typical lactoferrin doses 100–300 mg/day; effera® human-identical form may be effective at lower doses due to superior bioavailability Always follow the product label and check with a healthcare provider for personal advice.

Is effera safe, and does it have side effects?

For most healthy adults, effera is well tolerated at studied doses. Reported effects can include: Allergen-free (no dairy, no bovine proteins) — suitable for milk allergic individuals Precision fermentation production — no contamination risk from animal sources It may also interact with some medications. effera is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does effera interact with any medications?

Possible interactions include: Iron supplements — lactoferrin is a potent iron binder; space iron supplementation separately No significant pharmacokinetic drug interactions at supplement doses If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for effera?

NutraSmarts rates the evidence for effera as Moderate (3 out of 5). It is backed by 1 clinical trial and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Ali AS, Hasan SS, Kow CS, Merchant HA Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2021;45:26-32. doi: 10.1016/j.clnesp.2021.08.019.PubMedUsed to support: Meta-analysis of RCTs demonstrating lactoferrin supplementation significantly reduces risk of respiratory tract infections. Directly supports effera's broad-spectrum antimicrobial and immune activation claims. Constituent studies used bovine lactoferrin; effera® is human-identical lactoferrin (structurally closer to breast milk lactoferrin). No PubMed-indexed studies on effera® (Helaina) brand specifically.
  2. Vitetta L, Coulson S, Beck SL, Gramotnev H, Du S, Lewis S The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: a double blind randomized study. Complement Ther Med. 2013;21(3):164-71. doi: 10.1016/j.ctim.2012.12.006.PubMedUsed to support: Double-blind, randomized human trial showing lactoferrin-based supplementation reduced severity and duration of common cold symptoms. Supports effera's antimicrobial/antiviral protection and immune activation claims at the lactoferrin compound level.
  3. Dix C, Wright O Bioavailability of a Novel Form of Microencapsulated Bovine Lactoferrin and Its Effect on Inflammatory Markers and the Gut Microbiome: A Pilot Study. Nutrients. 2018;10(8):1115. doi: 10.3390/nu10081115.PubMedUsed to support: Human pilot RCT examining lactoferrin bioavailability and its effects on inflammatory markers and gut microbiome in adults. Supports effera's gut health and mucosal immunity claims at the lactoferrin compound level.